Beam Therapeutics Inc. (BEAM) came out with a quarterly loss of $1.1 per share versus the Zacks Consensus Estimate of a loss of$0.98. This compares to a loss of $1.17 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -12.24$1.04 per share when it actually produced a loss of $1, delivering a surprise of +3.85%.Over the last four quarters, the company has su ...